BTI
IBB icon

Blue Trust Inc’s iShares Biotechnology ETF IBB Stock Holding History

Blue Trust Inc’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$187K Sell
981
-1
-0.1% -$172 ﹤0.01% 807
2026
Q1 		$166K Buy
982
+18
+2% +$3.08K ﹤0.01% 834
2025
Q4 		$163K Buy
964
+29
+3% +$4.71K ﹤0.01% 853
2025
Q3 		$135K Sell
935
-244
-21% -$33.3K ﹤0.01% 953
2025
Q2 		$149K Buy
1,179
+34
+3% +$4.17K ﹤0.01% 879
2025
Q1 		$146K Buy
1,145
+57
+5% +$7.73K ﹤0.01% 831
2024
Q4 		$144K Buy
1,088
+200
+23% +$28.1K ﹤0.01% 774
2024
Q3 		$122K Sell
888
-9
-1% -$1.3K ﹤0.01% 1113
2024
Q2 		$123K Hold
897
– – ﹤0.01% 885
2024
Q1 		$123K Buy
897
+115
+15% +$15.7K ﹤0.01% 652
2023
Q4 		$96K Sell
782
-201
-20% -$24.5K ﹤0.01% 690
2023
Q3 		$125K Hold
983
– – ﹤0.01% 558
2023
Q2 		$127K Sell
983
-53
-5% -$6.88K ﹤0.01% 452
2023
Q1 		$136K Buy
1,036
+6
+0.6% +$785 ﹤0.01% 667
2022
Q4 		$120K Buy
1,030
+14
+1% +$1.81K ﹤0.01% 606
2022
Q3 		$119K Sell
1,016
-140
-12% -$17.4K ﹤0.01% 469
2022
Q2 		$151K Buy
+1,156
New +$137K ﹤0.01% 382

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Blue Trust Inc's IBB Position: Q2 2026 in Review

Blue Trust Inc reduced its iShares Biotechnology ETF (IBB) stake by 0.1% in Q2 2026, selling an estimated $172 and leaving 981 shares worth $187K. The position accounts for ﹤0.01% of the portfolio, ranked #807.

Blue Trust Inc first reported a position in IBB in Q2 2022 and has held it in 17 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Blue Trust Inc held 981 shares of iShares Biotechnology ETF worth $187K as of Q2 2026.
  • Blue Trust Inc sold 1 iShares Biotechnology ETF share in Q2 2026, an estimated $172.
  • iShares Biotechnology ETF made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #807 holding.
  • Blue Trust Inc first reported a position in iShares Biotechnology ETF in Q2 2022 and has held it in 17 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.